|       Total N (%) | No. of resistant mutations | Resistance rate (%) | |
---|---|---|---|---|
Total | 299 | (100) | 13 | 4.5 |
Gender | Â | Â | Â | Â |
Male | 168 | (56.2) | 7 | 4.3 |
Female | 131 | (43.8) | 6 | 4.8 |
Age | Â | Â | Â | Â |
≤25 | 75 | (25.1) | 3 | 4.2 |
26-35 | 130 | (43.5) | 6 | 4.8 |
36-45 | 58 | (19.4) | 4 | 7.4 |
>45 | 36 | (12.0) | 0 | 0 |
Transmission routes | Â | Â | Â | Â |
Heterosexual | 227 | (75.9) | 8 | 3.7 |
Intravenous drug injection | 52 | (17.4) | 5 | 10.6 |
Homosexual | 2 | (0.7) | 0 | 0 |
Mother to child | 4 | (1.3) | 0 | 0 |
Unknown | 14 | (4.7) | 0 | 0 |
Ethnicity | Â | Â | Â | Â |
Han | 122 | (40.8) | 3 | 2.5 |
Jingpo | 98 | (32.8) | 7 | 7.7 |
Dai | 64 | (21.4) | 2 | 3.2 |
Others | 15 | (5.0) | 1 | 7.1 |
CD4 + Count (cells/μl) |  |  |  |  |
≤200 | 21 | (7.0) | 1 | 5.0 |
201-350 | 64 | (21.4) | 3 | 4.9 |
351-500 | 88 | (29.4) | 4 | 4.8 |
≥501 | 126 | (42.1) | 5 | 4.1 |
HIV-1 Subtype | Â | Â | Â | Â |
C | 129 | (43.1) | 7 | 5.7 |
URFs | 55 | (18.4) | 2 | 3.8 |
CRF01_AE | 53 | (17.7) | 1 | 1.9 |
B | 32 | (10.7) | 2 | 6.7 |
CRF08_BC | 25 | (8.4) | 1 | 4.2 |
CRF07_BC | 5 | (1.7) | 0 | 0.0 |